image
Nu Skin Enterprises, Inc. NUS
Consumer Defensive - Household & Personal Products - NYSE - US
Watchlist
$ 6.22
-3.42 %
$ 309 M
Market Cap
-2.11
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one NUS stock under the worst case scenario is HIDDEN Compared to the current market price of 6.22 USD, Nu Skin Enterprises, Inc. is HIDDEN

NUS Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one NUS stock under the base case scenario is HIDDEN Compared to the current market price of 6.22 USD, Nu Skin Enterprises, Inc. is HIDDEN

NUS Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one NUS stock under the best case scenario is HIDDEN Compared to the current market price of 6.22 USD, Nu Skin Enterprises, Inc. is HIDDEN

NUS Intrinsic Value
HIDDEN
SHOW
2. FUNDAMENTAL ANALYSIS

Price Chart NUS

image
1M -31%
6M --%
1Y -104%
3Y -578%
5Y -229%
All
$8.5$8.5$8.0$8.0$7.5$7.5$7.0$7.0$6.5$6.5$6.0$6.0$5.5$5.515 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
1.73 B REVENUE
-12.04%
Growth Rates
1Year -12.04%
3Years -13.71%
5Years -6.47%
7Years -3.84%
10Years -3.87%
-152 M OPERATING INCOME
-314.05%
Growth Rates
1Year -314.05%
3Years -18.11%
5Years -12.41%
7Years -6.48%
10Years -3.64%
-147 M NET INCOME
-1705.57%
Growth Rates
1Year -1705.57%
3Years -25.90%
5Years -13.03%
7Years -11.43%
10Years -5.91%
112 M OPERATING CASH FLOW
-5.81%
Growth Rates
1Year -5.81%
3Years -7.59%
5Years -8.88%
7Years -13.26%
10Years 14.81%
-38 M INVESTING CASH FLOW
71.78%
Growth Rates
1Year 71.78%
3Years 24.65%
5Years 11.87%
7Years 11.87%
10Years 8.44%
-133 M FINANCING CASH FLOW
-1241.16%
Growth Rates
1Year -1241.16%
3Years -8.35%
5Years 2.96%
7Years 2.55%
10Years -12.48%
446 M REVENUE
3.58%
Growth Rates
1Year -12.04%
3Years -13.71%
5Years -6.47%
7Years -3.84%
10Years -3.87%
-53.1 M OPERATING INCOME
-291.16%
Growth Rates
1Year -314.05%
3Years -18.11%
5Years -12.41%
7Years -6.48%
10Years -3.64%
-36.1 M NET INCOME
-434.90%
Growth Rates
1Year -1705.57%
3Years -25.90%
5Years -13.03%
7Years -11.43%
10Years -5.91%
25.8 M OPERATING CASH FLOW
-17.97%
Growth Rates
1Year -5.81%
3Years -7.59%
5Years -8.88%
7Years -13.26%
10Years 14.81%
-13.6 M INVESTING CASH FLOW
-108.06%
Growth Rates
1Year 71.78%
3Years 24.65%
5Years 11.87%
7Years 11.87%
10Years 8.44%
-43.6 M FINANCING CASH FLOW
-51.59%
Growth Rates
1Year -1241.16%
3Years -8.35%
5Years 2.96%
7Years 2.55%
10Years -12.48%
Balance Sheet Nu Skin Enterprises, Inc.
image
Current Assets 539 M
Cash & Short-Term Investments 198 M
Receivables 50.8 M
Other Current Assets 290 M
Non-Current Assets 930 M
Long-Term Investments 39.6 M
PP&E 452 M
Other Non-Current Assets 439 M
13.48 %3.46 %19.73 %30.78 %29.85 %Total Assets$1.5b
Current Liabilities 297 M
Accounts Payable 34.9 M
Short-Term Debt 30 M
Other Current Liabilities 232 M
Non-Current Liabilities 521 M
Long-Term Debt 422 M
Other Non-Current Liabilities 98.8 M
4.27 %3.67 %28.35 %51.63 %12.09 %Total Liabilities$817.5m
EFFICIENCY
Earnings Waterfall Nu Skin Enterprises, Inc.
image
Revenue 1.73 B
Cost Of Revenue 550 M
Gross Profit 1.18 B
Operating Expenses 1.33 B
Operating Income -152 M
Other Expenses -4.99 M
Net Income -147 M
2b2b2b2b1b1b1b1b1b1b800m800m600m600m400m400m200m200m00(200m)(200m)2b(550m)1b(1b)(152m)5m(147m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
68.23% GROSS MARGIN
68.23%
Averages
1Year 68.23%
3Years 69.60%
5Years 71.66%
7Years 72.94%
10Years 74.41%
-8.75% OPERATING MARGIN
-8.75%
Averages
1Year -8.75%
3Years -0.44%
5Years 3.47%
7Years 4.89%
10Years 6.76%
-8.46% NET MARGIN
-8.46%
Averages
1Year -8.46%
3Years -1.11%
5Years 1.91%
7Years 3.04%
10Years 3.94%
-22.50% ROE
-22.50%
Averages
1Year -22.50%
3Years -3.26%
5Years 5.55%
7Years 9.02%
10Years 11.92%
-9.98% ROA
-9.98%
Averages
1Year -9.98%
3Years -1.25%
5Years 2.75%
7Years 4.39%
10Years 5.74%
-10.56% ROIC
-10.56%
Averages
1Year -10.56%
3Years -0.31%
5Years 4.35%
7Years 5.80%
10Years 7.82%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Nu Skin Enterprises, Inc.
image
350m350m300m300m250m250m200m200m150m150m100m100m50m50m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -147 M
Depreciation & Amortization 69.8 M
Capital Expenditures -41.6 M
Stock-Based Compensation 14.8 M
Change in Working Capital 0
Others 229 M
Free Cash Flow 70.2 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Nu Skin Enterprises, Inc.
image
Wall Street analysts predict an average 1-year price target for NUS of $11 , with forecasts ranging from a low of $11 to a high of $11 .
NUS Lowest Price Target Wall Street Target
11 USD 76.85%
NUS Average Price Target Wall Street Target
11 USD 76.85%
NUS Highest Price Target Wall Street Target
11 USD 76.85%
Price
Max Price Target
Min Price Target
Average Price Target
141413131212111110109988776655May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
0.87% DIVIDEND YIELD
0.06 USD DIVIDEND PER SHARE
Q1
Q2
Q3
Q4
1.6001.6001.4001.4001.2001.2001.0001.0000.8000.8000.6000.6000.4000.4000.2000.2000.0000.0000.350.3550.360.3650.370.3750.380.3850.390.060.060.350.3550.360.3650.370.3750.380.3850.390.060.350.3550.360.3650.370.3750.380.3850.390.060.351.400.3551.420.361.440.3651.460.371.480.3751.500.381.520.3851.540.061.230.180.062015201520162016201720172018201820192019202020202021202120222022202320232024202420252025
Download SVG
Download PNG
Download CSV
5. COMPETITION
slide 2 of 5
6. Ownership
Insider Ownership Nu Skin Enterprises, Inc.
image
Sold
0-3 MONTHS
13.1 K USD 1
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
71.7 K USD 2
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Nu Skin Enterprises to Announce First Quarter 2025 Financial Results PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release first quarter 2025 results after the market closes on Thursday, May 8. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m. ET. During the call, management will discuss recent results and upcoming business initiatives. The webcast of the conference call, including the financial information presented, will be available on the investor. businesswire.com - 2 weeks ago
5 Value Stocks With Exciting EV-to-EBITDA Ratios to Scoop Up We have screened value stocks OPFI, NUS, BJRI, MRC and KT based on the EV-to-EBITDA ratio, which gives the true picture of valuation and earnings potential. zacks.com - 1 month ago
Top Beauty and Cosmetics Stocks in Focus Right Now Beauty and Cosmetics stocks like NUS, ULTA and SBH are thriving on innovation, digital engagement and strategic expansions. zacks.com - 1 month ago
Don't Overlook These Top Dividend Stocks Under $20: KT, PAX, NUS Here are three top-rated Zacks stocks to consider under $20 with generous dividends. zacks.com - 1 month ago
Is Nu Skin Enterprises (NUS) Outperforming Other Consumer Staples Stocks This Year? Here is how Nu Skin Enterprises (NUS) and Primo Brands (PRMB) have performed compared to their sector so far this year. zacks.com - 1 month ago
5 High Earnings Yield Value Stocks to Buy Amid Market Volatility Volatility looms with sticky inflation, a slowing economy and Trump's trade policies. Buy high-earnings-yield stocks like NUS, HRMY, PAHC, DAN and NRG. zacks.com - 1 month ago
Nu Skin Q4 Earnings Beat Estimates, Rhyz Revenues Increase Y/Y NUS Q4 results reflect lower revenues and higher earnings. The adjusted operating margin expands 130 bps y/y. zacks.com - 2 months ago
Nu Skin Enterprises, Inc. (NUS) Q4 2024 Earnings Call Transcript Nu Skin Enterprises, Inc. (NYSE:NUS ) Q4 2024 Earnings Conference Call February 13, 2025 5:00 PM ET Company Participants B.G. Hunt - Head of Investor Relations Ryan Napierski - President & Chief Executive Officer James Thomas - Chief Financial Officer Conference Call Participants Sydney Wagner - Jefferies Christina Xue - D.A. seekingalpha.com - 2 months ago
Nu Skin Enterprises (NUS) Q4 Earnings and Revenues Top Estimates Nu Skin Enterprises (NUS) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.37 per share a year ago. zacks.com - 2 months ago
Nu Skin Enterprises Reports Fourth Quarter and Full-year 2024 Results Above Company Revenue Guidance PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS) today announced fourth quarter and full-year 2024 results above its latest revenue guidance. Executive Summary Q4 2024 vs. Prior-year Quarter Revenue $445.6 million; (8.8)% (4.1)% FX impact or $(20.1) million Rhyz revenue $83.1 million; 27.7% Earnings Per Share (EPS) $(0.73) or $0.38 excluding restructuring and other charges, compared to $0.15 or $0.37 excluding restructuring and other charges Customers 831,972; (15)% Paid Affil. businesswire.com - 2 months ago
Nu Skin Gears Up for Q4 Earnings: What Surprise Awaits Investors? NUS' fourth-quarter 2024 results are likely to show the impacts of a tough operating backdrop and pressures within the direct selling industry. zacks.com - 2 months ago
Analysts Estimate Nu Skin Enterprises (NUS) to Report a Decline in Earnings: What to Look Out for Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 2 months ago
8. Profile Summary

Nu Skin Enterprises, Inc. NUS

image
COUNTRY US
INDUSTRY Household & Personal Products
MARKET CAP $ 309 M
Dividend Yield 0.87%
Description Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Contact 75 West Center Street, Provo, UT, 84601 https://www.nuskin.com
IPO Date Nov. 22, 1996
Employees 3100
Officers Mr. Mark L. Adams Chief Information Officer Mr. Blake M. Roney Founder Mr. Steven J. Lund J.D. Co-Founder & Executive Chairman of the Board Mr. Chayce David Clark Executive Vice President & General Counsel Mr. Steven Keith Hatchett Executive Vice President & Chief Product Officer Mr. James D. Thomas Executive Vice President & Chief Financial Officer Mr. Ryan S. Napierski President, Chief Executive Officer & Director Dr. Joseph Y. Chang Ph.D. Executive Vice President & Chief Scientific Officer Ms. Sandra N. Tillotson Founder Mr. Joe Sueper Senior Vice President & Chief Technology Officer